Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Nordmark Pharma GmbH is a German professional biopharmaceutical company with over 90 years of history, headquartered in Uetersen, Germany. It focuses on the R&D and production of active pharmaceutical ingredients and finished drugs derived from biological and bioengineering sources. It holds a global leading position in the niche segments of pancreatin and collagenase, and also provides one-stop CDMO services covering the entire process from R&D to regulatory submission for pharmaceutical companies worldwide.
Its core business is divided into two main sections: First, it provides full value chain services for partner pharmaceutical companies, ranging from active ingredient R&D, analysis, clinical trials, manufacturing to global regulatory submission support, covering a wide range of technical directions including classic biological extraction, microbial fermentation, mammalian cell culture, advanced cell therapy, and live biotherapeutics. Second, it sells biochemical reagents such as collagenase and neutral protease of different purity grades to scientific research and clinical institutions. Reagents are categorized into research grade and clinical GMP grade to meet the needs of different scenarios such as cell isolation and tissue dissociation.
Product pricing is not publicly available on the official website. Starting from 2026, research-grade products will be exclusively distributed globally by SERVA. GMP-grade products are handled directly by the original manufacturer or authorized distributors depending on the region, and quotes are provided individually based on product specifications and order volume.
The main advantages are its more than 90 years of accumulated industry experience, full production processes that comply with cGMP standards, FDA approval, high batch consistency, stable product quality, and an outstanding reputation in niche product areas such as collagenase. Its one-stop service also covers the full-process needs of customers. The drawbacks are that the official website has no Chinese interface, procurement is not transparent, domestic users in China have to work through import distributors, and lead times are relatively long.
This site is suitable for global biopharmaceutical companies, domestic biomedical research institutions, and clinical cell therapy R&D teams looking to source raw materials or order custom development services.
Chinese users can access the website directly without any proxy. All site content loads normally.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on nordmark-pharma.de official site.
nordmark-pharma.de is an Germany Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach nordmark-pharma.de directly.